Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter

E-ISSN： 1464-5491|32|4|438-439

ISSN： 0742-3071

Source： DIABETIC MEDICINE, Vol.32, Iss.4, 2015-04, pp. : 438-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neither Created Nor Destroyed

By Rutishauser Amanda

Journal of Medical Humanities, Vol. 34, Iss. 4, 2013-12 ,pp. : 507-508

Springer Publishing Company

Access to resources Recommend Favorite

To neither bleed nor clot: That is the question

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : 367-368

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neither property right nor heroic gift, neither sacrifice nor aporia: the benefit of the theoretical lens of sharing in donation ethics

By Zeiler Kristin

Medicine, Health Care and Philosophy, Vol. 17, Iss. 2, 2014-05 ,pp. : 171-181

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Neither property right nor heroic gift, neither sacrifice nor aporia: the benefit of the theoretical lens of sharing in donation ethics

By Zeiler Kristin

Medicine, Health Care and Philosophy, Vol. 17, Iss. 2, 2014-05 ,pp. : 321-321

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 598-602

John Wiley & Sons Inc

Access to resources Recommend Favorite